Evidence map›Paper›PMID 30038061›Full record

ReviewBioscience reports2018

Activation mechanisms of the Hippo kinase signaling cascade.

Sung Jun Bae, Xuelian Luo

Open access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 82 citations in OpenAlex.

  1. ROS: their roles in diminished ovarian reserve.Frontiers in endocrinology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.International journal of molecular sciences · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Association analysis of polymorphisms inFrontiers in genetics · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sung Jun BaeDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, U.S.A.
Xuelian LuoDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, U.S.A. xuelian.luo@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

Chemical approach to study autopalmitoylation of transcription factorsR01DK107651 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LUO, XUELIAN, WU, XU · 2016 to 2020
$1.9M
Activation mechanism of the tumor-suppressing MST-LATS kinase cascadeR01GM107415 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI LUO, XUELIAN · 2013 to 2016
$1.2M
NIDDK NIH HHS R01 DK107651NIGMS NIH HHS R01 GM107415
6 · The paper itself

Abstract

First discovered two decades ago through genetic screens in

Indexed as

Enzyme ActivationSignal TransductionAmino Acid SequenceAnimalsDrosophilaDrosophila ProteinsHippo KinasesHippo Signaling PathwayHumansIntracellular Signaling Peptides and ProteinsModels, MolecularPhosphorylationProtein MultimerizationProtein Serine-Threonine KinasesDrosophila ProteinsHippo Kinaseshpo protein, DrosophilaIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesHippo pathwayphosphatasephosphorylationSignal transductiontumor suppressors

Identifiers

PMID30038061
PMCPMC6131212
OpenAlexW2884728210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.